Evidence map›Paper›PMID 36882867›Full record

ArticleJournal of nanobiotechnology2023

Accelular nanofibrous bilayer scaffold intrapenetrated with polydopamine network and implemented into a full-thickness wound of a white-pig model affects inflammation and healing process.

Katarína Kacvinská, Veronika Pavliňáková, Petr Poláček, Lenka Michlovská, Veronika Hefka Blahnová, Eva Filová, Martin Knoz, Břetislav Lipový, Jakub Holoubek, Martin Faldyna and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Katarína KacvinskáCEITEC - Central European Institute of Technology, Brno University of Technology, Purkyňova 656/123, 612 00, Brno, Czech Republic.
Veronika PavliňákováCEITEC - Central European Institute of Technology, Brno University of Technology, Purkyňova 656/123, 612 00, Brno, Czech Republic.
Petr PoláčekCEITEC - Central European Institute of Technology, Brno University of Technology, Purkyňova 656/123, 612 00, Brno, Czech Republic.
Lenka MichlovskáCEITEC - Central European Institute of Technology, Brno University of Technology, Purkyňova 656/123, 612 00, Brno, Czech Republic.
Veronika Hefka BlahnováInstitute of Experimental Medicine of the Czech Academy of Sciences, Vídeňská142 20, 1083, Prague 4, Czech Republic.
Eva FilováInstitute of Experimental Medicine of the Czech Academy of Sciences, Vídeňská142 20, 1083, Prague 4, Czech Republic.
Martin KnozDepartment of Burns and Plastic Surgery, Faculty of Medicine, Institution Shared With University Hospital Brno, Masaryk University, Jihlavská, 20, 625 00, Brno, Czech Republic.
Břetislav LipovýCEITEC - Central European Institute of Technology, Brno University of Technology, Purkyňova 656/123, 612 00, Brno, Czech Republic.
Jakub HoloubekDepartment of Burns and Plastic Surgery, Faculty of Medicine, Institution Shared With University Hospital Brno, Masaryk University, Jihlavská, 20, 625 00, Brno, Czech Republic.
Martin FaldynaVeterinary Research Institute, Hudcova 296/70, 621 00, Brno, Czech Republic.
Zdeněk PavlovskýInstitute of Pathology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, 625 00, Czech Republic.
Monika VícenováVeterinary Research Institute, Hudcova 296/70, 621 00, Brno, Czech Republic.
Michaela CvanováInstitute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic.
Jiří JarkovskýInstitute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic.
Lucy VojtováCEITEC - Central European Institute of Technology, Brno University of Technology, Purkyňova 656/123, 612 00, Brno, Czech Republic. lucy.vojtova@ceitec.vutbr.cz.
University Hospital Brno · CZCentral European Institute of Technology · CZBrno University of Technology · CZCzech Academy of Sciences, Institute of Experimental Medicine · CZMasaryk University · CZVeterinary Research Institute · CZ

Funding

EU Horizon 2020 MSCA-RISE-2018 Research and Innovation Staff Exchange Programme, project ActiTOX under the Marie Skłodowska-Curie grant agreement 823981Ministerstvo Zdravotnictví Ceské Republiky 17-29874A and extended project no. NU22-08-00454Ministerstvo Zemědělství RO0518
6 · The paper itself

Abstract

Treatment of complete loss of skin thickness requires expensive cellular materials and limited skin grafts used as temporary coverage. This paper presents an acellular bilayer scaffold modified with polydopamine (PDA), which is designed to mimic a missing dermis and a basement membrane (BM). The alternate dermis is made from freeze-dried collagen and chitosan (Coll/Chit) or collagen and a calcium salt of oxidized cellulose (Coll/CaOC). Alternate BM is made from electrospun gelatin (Gel), polycaprolactone (PCL), and CaOC. Morphological and mechanical analyzes have shown that PDA significantly improved the elasticity and strength of collagen microfibrils, which favorably affected swelling capacity and porosity. PDA significantly supported and maintained metabolic activity, proliferation, and viability of the murine fibroblast cell lines. The in vivo experiment carried out in a domestic Large white pig model resulted in the expression of pro-inflammatory cytokines in the first 1-2 weeks, giving the idea that PDA and/or CaOC trigger the early stages of inflammation. Otherwise, in later stages, PDA caused a reduction in inflammation with the expression of the anti-inflammatory molecule IL10 and the transforming growth factor β (TGFβ1), which could support the formation of fibroblasts. Similarities in treatment with native porcine skin suggested that the bilayer can be used as an implant for full-thickness skin wounds and thus eliminate the use of skin grafts.

Indexed as

NanofibersAnimalsIndolesInflammationMiceOsmium CompoundsPolymersQuaternary Ammonium CompoundsSwinechloropentaammineosmium(III) chlorideIndolesOsmium CompoundspolydopaminePolymersQuaternary Ammonium CompoundsBilayerChitosanCollagenOxidized cellulosePolydopamineWound healing

Identifiers

PMID36882867
PMCPMC9990222
OpenAlexW4323359883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.